34 results
Thumbnail

D1.270 - Irish Infant Allergy and Nutrition: A Content Analysis of Public-Facing Online Guidance

Thumbnail

D1.273 - Burden of food allergy on daily life and emotions in children and parents: Insights from the IPAA French Cohort

Thumbnail

D1.274 - Evaluating adherence to and effectiveness of food allergy advice in parents of infants under 6 months old suffering from atopic dermatitis

Thumbnail

D1.264 - A Case of Chronic Food Protein-Induced Enterocolitis Syndrome triggered by Egg Yolk via Breast Milk

Thumbnail

D1.265 - Predicting Milk Ladder Outcomes for Management of IgE-Mediated Cow’s Milk Protein Allergy: Feature Selection Using Machine Learning Methods

Thumbnail

D1.266 - Phenotypes of IgE-mediated Cow’s Milk Protein Allergy in an Irish Cohort Using Latent Class Analysis

Thumbnail

D1.267 - Clinical Features and Dairy Triggers for Cow’s Milk Allergy among 342 Chinese Children in a University-affiliated Allergy Clinic in Hong Kong

Thumbnail

D1.268 - Advancing Paediatric Egg Allergy Management via Telemedicine: Outcomes of Remote Egg Ladder Support

Thumbnail

D1.271 - Parental Vaccine Hesitancy And Immunization Practices In Children With Food Allergy

Thumbnail

D1.272 - Improving Culinary Medicine and Food Allergy Knowledge Through a STEM-Integrated Medical-Student-Led Cooking Program for Youth in New Orleans

Thumbnail

D1.275 - Pollen-Food Allergy Syndrome among Final-Year Primary School Students in the City of Olsztyn and Olsztyn County, Poland: A Questionnaire-Based Cross-Sectional Study

Thumbnail

D1.277 - Selective goat’s and sheep’s milk anaphylaxis: Advocacy for mandatory food labeling of milk origins

Thumbnail

D1.437 - A Decade of Research on Janus Kinase Inhibitors in Atopic Dermatitis: A Global Bibliometric Analysis (2015–2024)

Thumbnail

D1.438 - Dupilumab for Moderate-to-Severe Atopic Dermatitis in Children and Adolescents: Real-Life Assessment of Efficacy and Safety

Thumbnail

D1.442 - Design and Preclinical Development of a Bispecific Antibody Targeting IL11 and TL1A

Thumbnail

D1.443 - Preclinical Development of a Dual LIGHT/TL1A Bispecific Antibody

Thumbnail

D1.446 - Lebrikizumab in patients with urticarial vasculitis - a case series

Thumbnail

D1.447 - Comparison of Disease Duration, Remission, and Other Disease-Related Parameters with the Duration of Omalizumab Treatment in Patients with Chronic Spontaneous Urticaria

Thumbnail

D1.448 - Long-Term Efficacy and Stability of Lebrikizumab in Treating Face/Head and Neck Involvement in Patients with Moderate-to-Severe Atopic Dermatitis

Thumbnail

D1.449 - A Phase 2, Open-Label Extension Study to Evaluate the Long-Term Safety and Efficacy of Briquilimab in Adults with Chronic Urticaria (Trial in Progress)